Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Mostrar 4 de 8
GEA Hilge ofrece una gama versátil de bombas centrífugas y de desplazamiento positivo para una amplia variedad de aplicaciones sensibles en las industrias de bebidas, alimentaria y farmacéutica.
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.
Los separadores de GEA están diseñados para aplicaciones a base de líquidos. Utilizan fuerza centrífuga y se emplean para separar suspensiones que consisten de dos o más fases de distinta densidad; por ejemplo, pueden separar líquido-líquido, líquido-líquido-sólido o líquido-sólido. También son eficaces para separar mezclas líquidas a la vez que ...
El innovador proceso de GEA marca un hito en el pretratamiento de biocombustibles como el aceite vegetal hidrotratado y el combustible de aviación sostenible. Al eliminar el proceso de decoloración, los fabricantes se benefician de un importante potencial de ahorro: más de un 50% menos de costes operativos y hasta un 12% menos de emisiones de CO2.
El cambio climático y el aumento de la población mundial ejercen una presión cada vez mayor sobre la industria alimentaria, que consume mucha energía, para alimentar a más personas sin afectar aún más al planeta. George Shepherd, Global Technical Sustainability Manager de GEA, explica cómo GEA utiliza sus conocimientos de ingeniería para ayudar a los procesadores a producir de forma más sostenible y, al mismo tiempo, aumentar la productividad.